Analysts’ Recent Ratings Updates for HCA Healthcare (HCA)

A number of research firms have changed their ratings and price targets for HCA Healthcare (NYSE: HCA):

• 1/7/2026 – HCA Healthcare had its price target raised by analysts at Wells Fargo & Company from $431.00 to $452.00. They now have an “equal weight” rating on the stock.
• 1/6/2026 – HCA Healthcare had its “market perform” rating reaffirmed by analysts at Sanford C. Bernstein. They now have a $503.00 price target on the stock.
• 1/5/2026 – HCA Healthcare had its price target raised by analysts at Truist Financial Corporation from $495.00 to $520.00. They now have a “buy” rating on the stock.
• 12/29/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 12/22/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 12/19/2025 – HCA Healthcare had its price target raised by analysts at Royal Bank Of Canada from $482.00 to $525.00. They now have an “outperform” rating on the stock.
• 12/18/2025 – HCA Healthcare had its price target raised by analysts at Mizuho from $505.00 to $520.00. They now have an “outperform” rating on the stock.
• 12/15/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 12/15/2025 – HCA Healthcare was downgraded by analysts at Morgan Stanley from an “equal weight” rating to an “underweight” rating. They now have a $425.00 price target on the stock.
• 12/11/2025 – HCA Healthcare had its price target raised by analysts at Robert W. Baird from $423.00 to $450.00. They now have a “neutral” rating on the stock.
• 12/8/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 12/1/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 11/27/2025 – HCA Healthcare was downgraded by analysts at Zacks Research from a “strong-buy” rating to a “hold” rating.
• 11/24/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.
• 11/17/2025 – HCA Healthcare had its “buy (b)” rating reaffirmed by analysts at Weiss Ratings.

HCA Healthcare Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, December 29th. Investors of record on Monday, December 15th were given a $0.72 dividend. The ex-dividend date was Monday, December 15th. This represents a $2.88 annualized dividend and a dividend yield of 0.6%. HCA Healthcare’s payout ratio is currently 11.13%.

Insider Buying and Selling

In other HCA Healthcare news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction that occurred on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total value of $1,843,990.68. Following the sale, the executive vice president owned 3,487 shares in the company, valued at approximately $1,652,105.73. The trade was a 52.74% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Company insiders own 1.30% of the company’s stock.

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.